Medline Industries recalled 236 medical procedure kits on December 12, 2025. The kits contain MASTISOL liquid adhesive that may cause butyrate tubing to crack. Patients and healthcare providers should stop using these kits immediately.
Medline kits were manufactured and distributed containing MASTISOL liquid adhesive which was recalled due to complaints that the butyrate tubing cracked during actuation of the vials of MASTISOL Liquid Adhesive.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medline Industries, LP or your healthcare provider for instructions. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recall includes the following kits: DEPAUL BASIC NEURO-LF (SKU DYNJ20028L), NEURO MINOR PACK (SKU DYNJ46546M), NEURO SHUNT PACK (SKU DYNJ54396K), NEURO PACK (SKU DYNJ59397Q), NEURO BASIC (SKU DYNJ904052L), PK NEURO SHUNT BUMC (SKU DYNJT6428). These kits were distributed nationwide.
The kits contain MASTISOL liquid adhesive recalled due to reports of butyrate tubing cracking during use. This malfunction poses a high risk of injury, particularly during medical procedures.
There have been no specific injury reports associated with this recall. However, the potential for injury exists due to the defective adhesive.
Stop using the recalled kits immediately. Follow the manufacturer’s instructions for return or disposal. Contact Medline Industries or your healthcare provider for further guidance.
For more information, reach Medline Industries at their official website or through the contact number provided in the recall notice.
Get instant alerts for recalls that affect you. Free forever.
Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,057 bags of Acyclovir Sodium Injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers should cease use immediately and contact the manufacturer for guidance.
Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.
Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.
Fresenius Kabi Compounding recalled 1,410 bags of ketamine HCl injection on February 5, 2026. The recall stems from a lack of assurance of sterility, posing a high health risk. Healthcare providers and consumers must stop using this product immediately.
Fresenius Kabi Compounding recalled 10,548 bags of thiamine HCl injection on February 5, 2026. The recall follows a lack of assurance of sterility, posing a high health risk. Affected products include several lots expiring between February and May 2026.
Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.
Pro Numb Tattoo Numbing Spray was recalled due to cGMP deviations. The recall affects products distributed nationwide in the USA. Consumers should stop using the spray immediately and contact Pro Numb Tattoo Numbing Spray LLC for guidance.